Results 151 to 160 of about 193,097 (307)

Observation of substrate diffusion and ligand binding in enzyme crystals using high-repetition-rate mix-and-inject serial crystallography. [PDF]

open access: yesIUCrJ, 2021
Pandey S   +39 more
europepmc   +1 more source

Quasi-stationary hydrodynamics in high repetition rate filamentation

open access: yes
We present the first experiments and characterization of filamentation at high energy and high repetition rates (= 10 kHz), showing a quasi-stationary depletion offering improved electric discharge triggering and guidelines for future laser filamentation
Wolf J. -P.   +7 more
core   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

First experiments with a water-jet plasma X-ray source driven by the novel high-power-high-repetition rate L1 Allegra laser at ELI Beamlines. [PDF]

open access: yesJ Synchrotron Radiat, 2021
Zymaková A   +7 more
europepmc   +1 more source

The effect of laser repetition rate on the LASiS synthesis of biocompatible silver nanoparticles in aqueous starch solution

open access: yes, 2013
Reza Zamiri,1 Azmi Zakaria,1,* Hossein Abbastabar Ahangar,2 Majid Darroudi,3 Golnoosh Zamiri,1 Zahid Rizwan,1 Gregor PC Drummen4,* 1Department of Physics, Faculty of Science, Universiti Putra Malaysia, Serdang, Selangor, Malaysia; 2Department of ...
Zamiri G   +6 more
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

High-repetition rate, inductively stabilized, long-pulse excimer laser

open access: yes, 1984
A high-repetition rate double discharge head laser is developed taking advantage of the increased pulse repetition rate capabilities of inductive ...
Sze, R.C.
core  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy